The FDA clarified Thursday that it won't take action against GLP-1 compounders for certain violations while it reevaluates ...

A new study reveals that glucagon-like peptide-1 receptor agonists (GLP-1), which include weight loss and diabetes med ...

Only 15% of those who start a glucagon-like peptide 1 (GLP-1) for weight loss are still taking it two years according to ...

Weight loss drugs have risen in popularity in the recent years, but a disconnect remains between those who need the drugs and ...

U.S. consumer groups and two large labor unions urged the U.S. Federal Trade Commission on Thursday to block Novo Holdings, ...

A review of the medical records of thousands of adolescents treated for obesity found that kids who received the GLP-1 medications semaglutide or liraglutide were less likely to ...

The New York Times: Ozempic's Next Magic Trick: Treating Drug Addiction Could these medications — collectively known as GLP-1 receptor agonists — also fight America’s most difficult drug ...

Newer weight loss drugs are cost effective in the long term only when combined with bariatric weight loss surgery, according ...

GLP-1 receptor agonists and similar drugs may protect people with opioid or alcohol use disorder from opioid overdose and ...

Semaglutide and tirzepatides, the active ingredients in drugs including Mounjaro and Ozempic, have been hailed as a ...

Weight-loss drugs such as Ozempic, made by Denmark’s Novo Nordisk, can reduce rates of opioid and alcohol abuse by up to 50%, ...

New, popular injectable weight loss drugs — GLP-1 drugs — are highly effective at reducing obesity and, probably, the health ...